Citadel Advisors’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Hold |
0
| – | – | – | 7240 |
|
|
2024
Q4 | – | Hold |
0
| – | – | – | 6993 |
|
|
2024
Q3 | – | Sell |
-26,622
| Closed | -$137K | – | 6932 |
|
|
2024
Q2 | $137K | Buy |
+26,622
| New | +$137K | ﹤0.01% | 4818 |
|
|
2024
Q1 | – | Sell |
-6,180
| Closed | -$48.1K | – | 6958 |
|
|
2023
Q4 | $48.1K | Buy |
+6,180
| New | +$48.1K | ﹤0.01% | 5128 |
|
|
2022
Q3 | – | Sell |
-2,239
| Closed | -$22K | – | 6868 |
|
|
2022
Q2 | $22K | Sell |
2,239
-10,571
| -83% | -$104K | ﹤0.01% | 5699 |
|
|
2022
Q1 | $152K | Buy |
12,810
+6,475
| +102% | +$76.8K | ﹤0.01% | 5453 |
|
|
2021
Q4 | $206K | Sell |
6,335
-618
| -9% | -$20.1K | ﹤0.01% | 5451 |
|
|
2021
Q3 | $311K | Sell |
6,953
-1,172
| -14% | -$52.4K | ﹤0.01% | 4997 |
|
|
2021
Q2 | $443K | Sell |
8,125
-61,703
| -88% | -$3.36M | ﹤0.01% | 4831 |
|
|
2021
Q1 | $5.22M | Buy |
69,828
+59,400
| +570% | +$4.44M | ﹤0.01% | 2045 |
|
|
2020
Q4 | $1.13M | Buy |
+10,428
| New | +$1.13M | ﹤0.01% | 3126 |
|
|
2020
Q3 | – | Sell |
-1,258
| Closed | -$134K | – | 5389 |
|
|
2020
Q2 | $134K | Buy |
+1,258
| New | +$134K | ﹤0.01% | 4183 |
|
|
2019
Q1 | – | Sell |
-2,376
| Closed | -$132K | – | 5126 |
|
|
2018
Q4 | $132K | Buy |
+2,376
| New | +$132K | ﹤0.01% | 3954 |
|
|
2018
Q3 | – | Sell |
-1,821
| Closed | -$186K | – | 4816 |
|
|
2018
Q2 | $186K | Buy |
+1,821
| New | +$186K | ﹤0.01% | 3705 |
|
|
2017
Q4 | – | Sell |
-6,625
| Closed | -$975K | – | 4348 |
|
|
2017
Q3 | $975K | Buy |
+6,625
| New | +$975K | ﹤0.01% | 2293 |
|